A life-extending prostate cancer drug is to be made available to thousands of men in England in a matter of weeks, after a ...

Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have launched a clinical trial, called ANDROMEDA, to ...

The decision means Northern Ireland remains the only country in the UK where patients with this stage of prostate cancer are ...

In a previous study, the researchers showed that PSA scores can impact both doctor and patient behavior, leading to biopsy ...

Anyone discouraged by the continued absence of a prostate cancer screening programme, the difficulties in getting a clear ...

University Hospitals Seidman Cancer Center researchers have developed a tool that could identify metastatic prostate cancer ...

Thousands of men battling prostate cancer are set to gain access to a life-extending drug on the NHS following a significant ...

A research team at the University of Würzburg has, for the first time, uncovered how E. coli bacteria sneak into the prostate ...

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

Benign prostate hyperplasia (BPH) is a non-cancerous enlargement of the prostate gland, which is generally the shape and size ...

In this analysis, researchers aimed to evaluate the clinicopathologic characteristics, metastatic patterns, and survival outcomes in patients with metastatic prostate cancer and low-volume primary ...

Q. You recently wrote that testosterone does not increase the risks for heart attacks. But you overlooked the real risk of testosterone therapy: cancer!